Market Overview: The Hunter Syndrome Treatment Market represents the segment dedicated to diagnosing and treating Hunter Syndrome (Mucopolysaccharidosis II or MPS II) which is a rare X-linked recessive lysosomal storage disorder that occurs due to iduronate-2-sulfatase enzyme deficiency. The condition leads to the accumulation of glycosaminoglycans (GAGs) throughout various tissues and...